Abstract:The aberrant expression of Matrix Metalloproteinases (MMPs) is known to contribute to the pathogenesis of airway remodeling and alveolar disruption in chronic obstructive pulmonary diseases (COPD). This study explored the relationship between MMP genetic variants and the risk of COPD in family and population based studies. For the discovery stages, eleven COPD patients from five families were subjected to whole genome sequencing (WGS), and 21 common mutations in MMPs and TIMPs were identified. Of these mutations, two SNPs rs2664370 and rs2664369 in MMP16 remained significant differences (P < 0.0024 and P < 0.0024, respectively). In subsequent verification studies, the mutations were genotyped by SNPscan technology in 590 unrelated patients and 594 controls. Functionally, we found that MMP16 expression significantly increased in COPD patients and Cigarette Smoke Extract (CSE) treated 16HBE cells compared to controls. This was also confirmed by bioinformatic analysis. COPD subjects carrying rs2664370C alleles showed decreased levels of MMP16 in the plasma and PBMCs compared to those carrying CT and TT alleles. Treatment with hsa-miR-576-5p mimics led to a greater reduction in luciferase reporter activity in cells co-transfected with rs2664370CC. In addition, Base Excess (BE), PCO2 and PO2 levels in rs2664370CC were significantly lower than rs2664370CT+TT (P < 0.001, P = 0.019, and P = 0.026, respectively). Taken together, this demonstrates that the rs2664370T>C variant decreases the risk of COPD likely thorough increasing the interaction with hsa-miR-576-5p and reducing the expression of MMP16. Therefore, common mutations in MMP16 reduce COPD risk and improve plasma blood gas levels.Funding Statement: This work was supported by grants from the National Natural Science Foundation of China (81520108001, 81700043, 81770043, and 81220108001), Guangdong Natural Science Foundation (2016A030313593), Guangzhou Science and Technology Programs for Science Study (201607020030), the National Key R&D Project (2016YFC 0903700), the 973 Key Scheme of China (2015CB553406), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014, for WL), Guangdong Province Universities and Colleges Key Grant for Innovative Research (cxzd1142), Guangzhou Department of Education (1201620007, 13C08, and 12A001S), Open Project of State Key Laboratory of Respiratory Disease (SKLRD-OP-201808, SKLRD-QN-201719), Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2017BT01S155), and the National Key R&D Program of China (2018YFC1311900). Declaration of Interests: The authors declare: "None."Ethics Approval Statement: The study was approved by the Institutional Review Board of Guangzhou Medical University (Ethics Committee of the First Affiliated Hospital (GZMC2009-08-1336)) and adhered to the Declaration of Helsinki as previously described.

Gene and miRNA expression profiles in peripheral blood mononuclear cells (PBMCs) and sputum samples from patients with COPD with and without PiZZ- alpha1 antitrypsin deficiency

Gene Expression Networks in COPD: Microrna and Mrna Regulation

Identifying targets for COPD treatment through gene expression analyses.

An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation

Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease: miRNA and mRNA Regulation

Peripheral Blood Mononuclear Cell Gene Expression Associated with Pulmonary Microvascular Perfusion: The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease

Gene Expression Profiling in Patients with Chronic Obstructive Pulmonary Disease and Lung Cancer

RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD

Pattern of Expression of Genes Involved in Systemic Inflammation and Glutathione Metabolism Reveals Exacerbation of COPD

CD19 and POU2AF1 are Potential Immune-Related Biomarkers Involved in the Emphysema of COPD: On Multiple Microarray Analysis

Identification of Genes Related to Endoplasmic Reticulum Stress (ERS) in Chronic Obstructive Pulmonary Disease (COPD) and Clinical Validation

Posttranscriptional Gene Regulatory Networks in Chronic Airway Inflammatory Diseases: In silico Mapping of RNA-Binding Protein Expression in Airway Epithelium

An integrative network-based approach to identify driving gene communities in chronic obstructive pulmonary disease

High Serum Level of IL-17 in Patients with Chronic Obstructive Pulmonary Disease and the Alpha-1 Antitrypsin PiZ Allele

Genetic Screening of MMP1 As a Potential Pathogenic Gene in Chronic Obstructive Pulmonary Disease

Immune Characteristics Analysis and Transcriptional Regulation Prediction Based on Gene Signatures of Chronic Obstructive Pulmonary Disease

Pulmonary microRNA profiling: implications in upper lobe predominant lung disease

Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease

Peripheral blood microbial signatures in COPD

Hub genes PRPF19 and PPIB in relation to COPD: A Mendelian Randomization investigation

A Functional Mutation in Rs2664370 (T > C) in the 3'UTR of MMP16 Decreases the Risk of COPD Through Interactions with Mir-576-5p: A Family and Population Based Study